Figure 1. Therapeutic strategies using cells in ALS.

Figure 1

Therapeutic strategies using cells in ALS. Neural stem cells from different sources could be used to replace motoneurons or glial cells, while mesenchymal stem cells or mononuclear blood cells have been tested mainly as immunomodulators. Genetic manipulations, such as growth factors superexpression, can improve cells therapeutic potential. Created using https://smart.servier.com/.

From: Chapter 7, Cell-based Research and Therapy for Amyotrophic Lateral Sclerosis: Promises and Challenges

Cover of Amyotrophic Lateral Sclerosis
Amyotrophic Lateral Sclerosis [Internet].
Araki T, editor.
Brisbane (AU): Exon Publications; 2021 Jul 25.
Copyright: The Authors.

Licence: This open access article is licenced under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0) https://creativecommons.org/licenses/by-nc/4.0/

NCBI Bookshelf. A service of the National Library of Medicine, National Institutes of Health.